These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20721692)

  • 21. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
    Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn screening for inborn errors of metabolism: a systematic review.
    Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
    Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Austrian Newborn Screening Program: a perspective of five decades.
    Pollak A; Kasper DC
    J Perinat Med; 2014 Mar; 42(2):151-8. PubMed ID: 24225125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
    DiBattista A; McIntosh N; Lamoureux M; Al-Dirbashi OY; Chakraborty P; Britz-McKibbin P
    J Proteome Res; 2019 Mar; 18(3):841-854. PubMed ID: 30507207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.
    Thomason MJ; Lord J; Bain MD; Chalmers RA; Littlejohns P; Addison GM; Wilcox AH; Seymour CA
    J Public Health Med; 1998 Sep; 20(3):331-43. PubMed ID: 9793900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
    Zytkovicz TH; Fitzgerald EF; Marsden D; Larson CA; Shih VE; Johnson DM; Strauss AW; Comeau AM; Eaton RB; Grady GF
    Clin Chem; 2001 Nov; 47(11):1945-55. PubMed ID: 11673361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Advances for Newborn Screening of Inborn Errors of Metabolism by Capillary Electrophoresis-Mass Spectrometry (CE-MS).
    Shanmuganathan M; Britz-McKibbin P
    Methods Mol Biol; 2019; 1972():139-163. PubMed ID: 30847789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry (CE-ESI-MS).
    Britz-McKibbin P
    Methods Mol Biol; 2013; 919():43-56. PubMed ID: 22976089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of Underivatized Amino Acids on Dry Blood Spot, Plasma, and Urine by HPLC-ESI-MS/MS.
    Giordano G; Gucciardi A; Pirillo P; Naturale M
    Methods Mol Biol; 2019; 2030():153-172. PubMed ID: 31347117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
    Wang S; Leng J; Diao C; Wang Y; Zheng R
    J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan.
    Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Sakura N; Tajima T; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):39-48. PubMed ID: 12127323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience.
    Marsden D
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():111-4. PubMed ID: 15906712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China.
    Ma S; Guo Q; Zhang Z; He Z; Yue A; Song Z; Zhao Q; Wang X; Sun R
    J Clin Lab Anal; 2020 May; 34(5):e23159. PubMed ID: 31916308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective ESI-MS/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Inherit Metab Dis; 2007 Aug; 30(4):606. PubMed ID: 17641825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland--experience and development of a routine program for expanded newborn screening.
    Lund AM; Hougaard DM; Simonsen H; Andresen BS; Christensen M; Dunø M; Skogstrand K; Olsen RK; Jensen UG; Cohen A; Larsen N; Saugmann-Jensen P; Gregersen N; Brandt NJ; Christensen E; Skovby F; Nørgaard-Pedersen B
    Mol Genet Metab; 2012 Nov; 107(3):281-93. PubMed ID: 22795865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public health explores expanding newborn screening for cystic fibrosis, congenital adrenal hyperplasia, and medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD).
    Rhoades E; King P
    J Okla State Med Assoc; 2001 Apr; 94(4):129-32. PubMed ID: 11392180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.